Litcius/Paper detail

Convalescent serum lines up as first-choice treatment for coronavirus

Cormac Sheridan

2020Nature Biotechnology51 citationsDOI

Topics & Concepts

Polyclonal antibodiesAntibodyCoronavirus disease 2019 (COVID-19)VirologyRecombinant DNASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusImmunologyMedicineBiologyInternal medicineInfectious disease (medical specialty)OutbreakGeneticsDiseaseGeneSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Convalescent serum lines up as first-choice treatment for coronavirus | Litcius